Table 2.

Summary of previous therapy for NSCLC

Erlotinib (n = 488), n (%)Placebo (n = 243), n (%)
Previous therapy
    Chemotherapy488 (100)243 (100)
    Surgery487 (100)242 (100)
    Radiation264 (54)143 (59)
    Hormonal therapy1 (<1)1 (<1)
    Other prior therapy2 (<1)2 (<1)
No. prior chemotherapy
    Regimens
        1243 (50)121 (50)
        2238 (49)119 (49)
        37 (1)3 (1)
Prior platinum therapy
    No34 (7)19 (8)
    Yes454 (93)224 (92)
Prior taxane therapy
    No311 (64)153 (63)
    Yes177 (36)90 (37)